Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-006609
Filing Date
2025-03-04
Accepted
2025-03-04 17:21:08
Documents
1
Period of Report
2025-03-01

Document Format Files

Seq Description Document Type Size
1 form4-03042025_100305.html 4  
1 form4-03042025_100305.xml 4 5733
  Complete submission text file 0001415889-25-006609.txt   7146
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Issuer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O FUSION PHARMACEUTICALS, INC. 270 LONGWOOD ROAD SOUTH HAMILTON D0 L8P OA6
Business Address
Lee Philina (Reporting) CIK: 0001845080 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37359 | Film No.: 25706509